Tag:

Rheumatoid Arthritis

CAR T Cells for Severe Rheumatoid Arthritis: What the First Charité Trial Shows

A first clinical trial at Charité–Universitätsmedizin Berlin suggests that CD19 CAR T-cell therapy may reduce disease activity in people with severe rheumatoid arthritis that...

A New Paradigm in Rheumatoid Arthritis Management: The Importance of Integrating Biopsychosocial Factors

Recent studies published in authoritative medical journals—Nature Reviews Rheumatology and The Lancet Rheumatology—examining the influence of biological, psychological, and social factors in the management...

Biological Heterogeneity of Refractory Rheumatoid Arthritis

Rheumatoid Arthritis (RA) presents a clinical challenge, especially when dealing with Refractory RA, because standard therapy fails to improve the patient's condition. A new...